According to the technical manual on hepatitis from the Brazilian Ministry of Health, published in 2018, the HBV NAT test detects the presence of viral particles in the acute and chronic phases of hepatitis B, starting at 10 copies/mL of plasma or serum with a specificity above 99% [17,18]. This evidence concerns the gene BRD2 and hepatitis A virus infection.